
Investors
Long-term value creation in our core spaces for our stakeholders with a distinct purpose of ensuring that every family will have a better tomorrow


Financial Snapshot
74
Years in Operation
USD
104 mn
Market Capitalisation35%
Free Float
USD
256 mn
Total AssetsAAA
Long-term Fitch Rating>5K
EmployeesLatest News
Hemas Pharmaceuticals partners with Zydus Wellness to launch Complan, a nutritious food supplement
Jan 4, 2023
Hemas Pharma Shuttlers Shine at the 38th Mercantile Badminton Association Inter-Firm Team Badminton Championship 2022
Jan 2, 2023
Rotaract in Rotary International District 3220 joins hands with Fems Aya to help end period poverty in Sri Lanka
Dec 26, 2022